Detailed Study of Clinical Manifestations in Muenke Syndrome (FGFR3-Related Craniosynostosis)
Data Collection
Collected from today forward - ProspectiveCongenital Abnormalities+21
+ Tarsal Coalition
+ Bone Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: March 31, 2005
Actual date on which the first participant was enrolled.Muenke Syndrome, a specific form of craniosynostosis, is a condition where a baby's skull bones fuse prematurely. This can lead to various health issues such as coronal suture craniosynostosis, developmental delay, deafness, and carpal and tarsal bone fusion. This study aims to deepen our understanding of Muenke Syndrome's clinical manifestations to improve early diagnosis and clinical management, including genetic counseling. The study focuses on individuals with Muenke Syndrome and plans to enroll approximately 10-20 probands, along with their family members each year, with a maximum enrollment of 200 probands. The study is observational and has three main parts. The first part involves detailed physical, developmental, neurologic, dental, ophthalmologic, otolaryngologic, audiologic, radiologic, and genetic/genomic studies at the NIH Clinical Center and Children's National Medical Center. The second part is a genetic/genomic study aiming to investigate factors that influence the severity and expression of the disease. The third part is a cognitive function, development, and hearing questionnaire that patients can complete online, via phone, or by mail. The primary outcome of this study is to enhance our understanding of the genetics and clinical characteristics of Muenke Syndrome.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.137 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 1 Months
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Childrens National Medical Center
Washington D.C., United StatesOpen Childrens National Medical Center in Google MapsNational Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, United States